One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.
Verywell Health on MSN1y
How Plaque Psoriasis Is Diagnosed
Medically reviewed by William Truswell, MD Getting a plaque psoriasis diagnosis is straightforward. Your healthcare provider ...
Plaque psoriasis is characterized by raised ... plaques may appear salmon with silvery-white scale, or violet or dark brown with gray scale. Plaques can crop up on any area of the body but ...
Verywell Health on MSN1y
Managing Psoriasis on the Arms
Medically reviewed by Susan Bard, MD Psoriasis frequently appears on the arms, often on your elbow. Several types of ...
Understand psoriasis and sunlight, recognize benefits of vitamin D, and learn about sun therapy. 8 Ways to Prevent Psoriasis Hair Loss Scalp psoriasis can cause hair damage and loss. Learn tips ...
Research shows lifestyle changes like diet, exercise, and smoking cessation can assist with improving psoriasis outcomes and ...
A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.
These quiz questions about plaque psoriasis are derived from the recent medical literature. Are you up to date? At the end of the quiz, compare your score with those of your physician colleagues.
First-of-its-kind Phase 3b study shows TREMFYA ® achieved statistical significance across all primary and secondary endpoints in low body surface area psoriasis with special site involvement ...
Brown and colleagues (2004) evaluated a study group of five patients with chronic plaque-type psoriasis on a home-based 6-month medical nutritional therapeutic regimen. The group consisted of two ...
moderate plaque psoriasis (PsO) with special site involvement who had failed topical treatment. Data from the Phase 3b SPECTREM study to measure skin clearance and other treatment outcomes in low ...
Patients with plaque psoriasis treated with Johnson & Johnson’s oral IL-23 inhibitor JNJ-2113 have been shown to maintain skin clearance for up to a year, pointing to a durable effect for a drug ...